FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058859067> ?p ?o ?g. }

• W2058859067 endingPage "122" @default.
• W2058859067 startingPage "113" @default.
• W2058859067 abstract "Abstract Background The health benefits of exercise increase in dose‐response fashion among cancer survivors. However, it is unclear how to identify cancer survivors who may require a pre‐exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate‐ to vigorous‐intensity exercise. Objective To clarify how to identify cancer survivors who should undergo a pre‐exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate‐ to vigorous‐intensity exercise. Design Electronic survey. Participants Forty‐seven (n = 47) experts in the field of exercise physiology, rehabilitation medicine, and cancer survivorship. Setting Not applicable. Methods We synthesized peer‐reviewed guidelines for exercise and cancer survivorship and identified 82 health factors that may warrant a pre‐exercise evaluation before a survivor engages in unsupervised moderate‐ to vigorous‐intensity exercise. The 82 health factors were classified into 3 domains: (1) clinical health factors; (2) comorbidity and device health factors; and (3) medications. We surveyed a sample of experts asking them to identify which of the 82 health factors among cancer survivors would indicate the need for a pre‐exercise evaluation before they engaged in moderate‐ to vigorous‐intensity exercise. Main Outcome Measurements The response rate to our survey was 75% (n = 47). Across the 3 domains of health factors, acute symptoms, comorbidities, and medications related to cardiovascular disease were agreed on to indicate a pre‐exercise evaluation for survivors before they engaged in unsupervised moderate‐ to vigorous‐intensity exercise. Other health factors in the survey included hematologic, musculoskeletal, systemic, gastrointestinal, pulmonary, and neurological symptoms and comorbidities. Eighteen experts (38%) said it was difficult to provide absolute answers because no 2 patients are alike, and their decisions are made on a case‐by‐case basis. Conclusions The results from this expert survey will help to identify which cancer survivors should undergo a pre‐exercise evaluation before they engage in unsupervised moderate‐ to vigorous‐intensity exercise." @default.
• W2058859067 created "2016-06-24" @default.
• W2058859067 creator A5051745638 @default.
• W2058859067 creator A5067029478 @default.
• W2058859067 creator A5068319278 @default.
• W2058859067 date "2014-09-10" @default.
• W2058859067 modified "2023-09-25" @default.
• W2058859067 title "Development of a Risk-Screening Tool for Cancer Survivors to Participate in Unsupervised Moderate- to Vigorous-Intensity Exercise: Results From a Survey Study" @default.
• W2058859067 cites W1659854146 @default.
• W2058859067 cites W1915426739 @default.
• W2058859067 cites W1968954035 @default.
• W2058859067 cites W1979565081 @default.
• W2058859067 cites W1980324708 @default.
• W2058859067 cites W1982724356 @default.
• W2058859067 cites W1982918955 @default.
• W2058859067 cites W1991445432 @default.
• W2058859067 cites W2007086823 @default.
• W2058859067 cites W2020532319 @default.
• W2058859067 cites W2023540185 @default.
• W2058859067 cites W2026121968 @default.
• W2058859067 cites W2040462758 @default.
• W2058859067 cites W2041670078 @default.
• W2058859067 cites W2041918383 @default.
• W2058859067 cites W2042528112 @default.
• W2058859067 cites W2048561042 @default.
• W2058859067 cites W2060504388 @default.
• W2058859067 cites W2062270028 @default.
• W2058859067 cites W2066028007 @default.
• W2058859067 cites W2077899509 @default.
• W2058859067 cites W2088648735 @default.
• W2058859067 cites W2093274439 @default.
• W2058859067 cites W2100160566 @default.
• W2058859067 cites W2101077754 @default.
• W2058859067 cites W2106011651 @default.
• W2058859067 cites W2107946734 @default.
• W2058859067 cites W2111862777 @default.
• W2058859067 cites W2112395080 @default.
• W2058859067 cites W2116614355 @default.
• W2058859067 cites W2118440600 @default.
• W2058859067 cites W2120077385 @default.
• W2058859067 cites W2120389637 @default.
• W2058859067 cites W2120969743 @default.
• W2058859067 cites W2122087165 @default.
• W2058859067 cites W2126050567 @default.
• W2058859067 cites W2126206943 @default.
• W2058859067 cites W2126209181 @default.
• W2058859067 cites W2128613674 @default.
• W2058859067 cites W2135104074 @default.
• W2058859067 cites W2135375808 @default.
• W2058859067 cites W2139219244 @default.
• W2058859067 cites W2147312821 @default.
• W2058859067 cites W2147790392 @default.
• W2058859067 cites W2152063594 @default.
• W2058859067 cites W2160769891 @default.
• W2058859067 cites W2162423956 @default.
• W2058859067 cites W2165229942 @default.
• W2058859067 cites W2170328295 @default.
• W2058859067 cites W2171100121 @default.
• W2058859067 cites W2172085565 @default.
• W2058859067 cites W2247997571 @default.
• W2058859067 cites W2323165288 @default.
• W2058859067 cites W2914053210 @default.
• W2058859067 cites W3021048901 @default.
• W2058859067 cites W4320300836 @default.
• W2058859067 cites W4320300890 @default.
• W2058859067 doi "https://doi.org/10.1016/j.pmrj.2014.09.003" @default.
• W2058859067 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4391374" @default.
• W2058859067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25217819" @default.
• W2058859067 hasPublicationYear "2014" @default.
• W2058859067 type Work @default.
• W2058859067 sameAs 2058859067 @default.
• W2058859067 citedByCount "11" @default.
• W2058859067 countsByYear W20588590672015 @default.
• W2058859067 countsByYear W20588590672017 @default.
• W2058859067 countsByYear W20588590672018 @default.
• W2058859067 countsByYear W20588590672019 @default.
• W2058859067 countsByYear W20588590672021 @default.
• W2058859067 countsByYear W20588590672022 @default.
• W2058859067 countsByYear W20588590672023 @default.
• W2058859067 crossrefType "journal-article" @default.
• W2058859067 hasAuthorship W2058859067A5051745638 @default.
• W2058859067 hasAuthorship W2058859067A5067029478 @default.
• W2058859067 hasAuthorship W2058859067A5068319278 @default.
• W2058859067 hasBestOaLocation W20588590672 @default.
• W2058859067 hasConcept C121608353 @default.
• W2058859067 hasConcept C126322002 @default.
• W2058859067 hasConcept C172400760 @default.
• W2058859067 hasConcept C1862650 @default.
• W2058859067 hasConcept C2776811442 @default.
• W2058859067 hasConcept C2777953023 @default.
• W2058859067 hasConcept C2779134260 @default.
• W2058859067 hasConcept C2779159551 @default.
• W2058859067 hasConcept C43893838 @default.
• W2058859067 hasConcept C71924100 @default.
• W2058859067 hasConcept C84393581 @default.
• W2058859067 hasConceptScore W2058859067C121608353 @default.
• W2058859067 hasConceptScore W2058859067C126322002 @default.
• W2058859067 hasConceptScore W2058859067C172400760 @default.

• next